⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416908 | 0.97 | — | — | |
| SCHEMBL217376 | 0.90 | — | — | |
| SCHEMBL7092395 | 0.90 | — | — | |
| SCHEMBL7341827 | 0.90 | — | — | |
| SCHEMBL358718 | 0.75 | — | — | |
| SCHEMBL8040334 | 0.67 | — | — | |
| SCHEMBL528403 | 0.63 | — | — | |
| SCHEMBL323151 | 0.63 | — | — | |
| SCHEMBL1399909 | 0.63 | — | — | |
| SCHEMBL4162100 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114302884-B | Substituted pyridopyrimidinone compounds useful as T cell activators | 百时美施贵宝公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117693508-A | Combination of T cell therapy and DGK inhibitors | 朱诺治疗学股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-111295382-B | Bridged bicyclic compounds as farnesyl ester X receptor modulators | 百时美施贵宝公司 | 2024-02-02 | — | — | CN | claimed |
| US-20240018154-A1 | NEW INDAZOLE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2024-01-18 | — | — | US | claimed |
| CN-111819176-B | 4-azaindole compounds | 百时美施贵宝公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4255906-A1 | NEW INDAZOLE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-10-11 | — | — | EP | claimed |
| CN-116710451-A | Novel aryl-pyrido-pyrimidin-one derivatives | 豪夫迈·罗氏有限公司 | 2023-09-05 | — | — | CN | claimed |
| EP-3766882-B1 | PHTHALAZINE ISOXAZOLE ALKOXY DERIVATIVES, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI SIMR BIOTECHNOLOGY CO LTD (CN) | 2023-08-23 | — | — | EP | claimed |
| CN-110256440-B | Phthalazine isoxazole alkoxy derivative, preparation method, pharmaceutical composition and application thereof | 上海赛默罗生物科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-111278817-B | Polycyclic compounds as farnesol X receptor modulators | 百时美施贵宝公司 | 2023-05-16 | — | — | CN | claimed |
| US-4238496-A | ANTIALLERGENS | BOEHRINGER INGELHEIM GMBH (DE) | 1980-12-09 | — | — | US | claimed |
| EP-0010313-A1 | 3,7-Disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-04-30 | — | — | EP | claimed |
| US-4145550-A | 2-(4-Substituted-1,2,5-thiadiazole-3-yloxy)-acetaldehydes | MERCK SHARP & DOHME (I.A.) CORP. (US) | 1979-03-20 | — | — | US | claimed |
| US-4127578-A | Diene intermediates for indantetrols | E. R. SQUIBB & SONS, INC. (US) | 1978-11-28 | — | — | US | claimed |
| US-4092318-A | HYPOTENSIVES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-30 | — | — | US | claimed |
| US-4060609-A | ANTICHOLESTEROL | MERCH PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-11-29 | — | — | US | claimed |
| US-4021551-A | INDUCERS FOR INTERFERON FORMATION | BOEHRINGER INGELHEIM GMBH (DT) | 1977-05-03 | — | — | US | claimed |
| US-3989832-A | Combating bacteria with nitroimidazolyl-triazolo-pyridiazine compounds | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-11-02 | — | — | US | claimed |
| US-3966936-A | MUSCLE RELAXANTS | PFIZER INC. (US) | 1976-06-29 | — | — | US | claimed |
| US-3932642-A | BACTERICIDES, FUNGICIDES, TRICHOMONOCIDES | BOEHRINGER INGELHEIM GMBH (DT) | 1976-01-13 | — | — | US | claimed |